Position in SNY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$77,830,098
-$10,344,842 QoQ
Shares Held
1,824,428
-0.3% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#31
of 712 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,636,745,309 across 13 Drug Manufacturers - General names. SNY ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,141,447 | $2,568,515,989 | |
| 2 | JNJ |
Johnson & Johnson
|
2,620,929 | $665,637,338 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
10,168,924 | $585,933,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,143,885 | $532,489,222 | |
| 5 | ABBV |
AbbVie Inc.
|
1,581,740 | $398,029,053 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,203,012 | $278,328,536 | |
| 7 | AMGN |
Amgen Inc
|
632,302 | $228,969,200 | |
| 8 | PFE |
Pfizer Inc
|
9,152,541 | $220,393,187 |
All Filings in SNY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,830,098 | 1,824,428 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $88,174,940 | 1,830,115 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $78,999,249 | 1,630,195 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $66,723,808 | 1,413,640 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,269,723 | 605,873 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $499,594 | 8,669 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $329,596 | 6,793 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $295,050 | 6,071 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,848,961 | 37,180 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,847,211 | 53,080 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,219,770 | 59,736 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $3,228,684 | 59,329 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,557,557 | 32,161 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $1,195,614 | 31,447 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,590,253 | 31,786 | Shares | Sole | 2022-08-01 | |
| No filing history on record for this holder in this stock. | ||||||